Clinical Trials for Cervical Cancer

202005122

First-in-human, open-label, dose-escalation trial with expansion cohorts to evaluate safety of GEN1046 in subjects with malignant solid tumors Phase I/II Principal Investigator Ward, Jeffrey Disease Site Anus; Bones and Joints; Breast; Cervix; Colon; Corpus Uteri;…

202101091

A Phase 2 Basket Study of Tucatinib in Combination with Trastuzumab in Subjects with Previously Treated, Locally-Advanced Unresectable or Metastatic Solid Tumors Driven by HER2 Alterations Phase II (Cancer Control) Principal Investigator Thaker, Premal Disease…